Results 131 to 140 of about 6,150 (181)

The islet tissue plasminogen activator/plasmin system is upregulated with human islet amyloid polypeptide aggregation and protects beta cells from aggregation-induced toxicity. [PDF]

open access: yesDiabetologia
Esser N   +13 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus

Physiological Reviews, 2011
Islet amyloid polypeptide (IAPP, or amylin) is one of the major secretory products of β-cells of the pancreatic islets of Langerhans. It is a regulatory peptide with putative function both locally in the islets, where it inhibits insulin and glucagon secretion, and at distant targets.
Per, Westermark   +2 more
openaire   +2 more sources

Islet Amyloid, Islet-Amyloid Polypeptide, and Diabetes Mellitus

New England Journal of Medicine, 1989
Islet-amyloid deposits, which are a common feature of Type II diabetes mellitus, are derived from the polymerization of a putative hormone identified as IAPP. IAPP is synthesized by normal islet beta cells and probably is cosecreted with insulin. Although the physiologic function of IAPP and its role in the pathogenesis of Type II diabetes mellitus are
Franklin H. Epstein   +4 more
openaire   +2 more sources

Islet Amyloid Polypeptide and Diabetes

Current Protein & Peptide Science, 2013
Islet amyloid polypeptide (IAPP, amylin) is a 37 amino acid residue hormone expressed mainly by pancreatic islet beta cells and to less extent by some gastrointestinal endocrine cells and by certain regions in central nervous system. In experimental systems a number of different effects have been ascribed to IAPP but the in vivo importance of many of ...
Gunilla T, Westermark, Per, Westermark
openaire   +2 more sources

Home - About - Disclaimer - Privacy